Loading headlines…
Collected headline brief
BRAZIL · ECONOMY Key Facts —The approval: Brazil’s health regulator cleared Ozivy, the country’s first home-grown version of the drug behind Ozempic. —The maker: It is produced by EMS, one of Brazil’s largest pharmaceutical companies. —Why…
There is more to this story
Complete reading on newsGlobal
Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →Full article · 4 min read
AI-generated editorial illustration / newsGlobal. Not a photograph of an actual event.
Read the full article →